Barry Lutz

Prof. Barry Lutz

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 May 2013 in Lab on a Chip
Verified
Journal Article
Closed access
PDF file
BLBarry Lutz
Barry Lutz
TLTinny Liang
Tinny Liang
EFElain Fu
Elain Fu
SRSujatha Ramachandran
Sujatha Ramachandran
PKPeter Kauffman
Peter Kauffman
PYPaul Yager
Paul Yager
Lateral flow tests (LFTs) are an ingenious format for rapid and easy-to-use diagnostics, but they are fundamentally limited to assay chemistries that can be reduced to a single chemical step. In contrast, most laboratory diagnostic assays rely on multiple timed steps carried out by a human or a machine. Here, we use dissolvable sugar applied to paper to create programmable flow delays and present a paper network topology that uses these time delays to program automated multi-step fluidic protocols. Solutions of sucrose at different concentrations (10–70% of saturation) were added to paper strips and dried to create fluidic time delays spanning minutes to nearly an hour. A simple folding card format employing sugar delays was shown to automate a four-step fluidic process initiated by a single user activation step (folding the card); this device was used to perform a signal-amplified sandwich immunoassay for a diagnostic biomarker for malaria. The cards are capable of automating multi-step assay protocols normally used in laboratories, but in a rapid, low-cost, and easy-to-use format.

28 October 2011 in Lab on a Chip
Verified
Journal Article
Closed access
PDF file
BLBarry Lutz
Barry Lutz
PTPhilip Trinh
Philip Trinh
CBCameron Ball
Cameron Ball
EFElain Fu
Elain Fu
PYPaul Yager
Paul Yager
Most laboratory assays take advantage of multi-step protocols to achieve high performance, but conventional paper-based tests (e.g., lateral flow tests) are generally limited to assays that can be carried out in a single fluidic step. We have developed two-dimensional paper networks (2DPNs) that use materials from lateral flow tests but reconfigure them to enable programming of multi-step reagent delivery sequences. The 2DPN uses multiple converging fluid inlets to control the arrival time of each fluid to a detection zone or reaction zone, and it requires a method to disconnect each fluid source in a corresponding timed sequence. Here, we present a method that allows programmed disconnection of fluid sources required for multi-step delivery. A 2DPN with legs of different lengths is inserted into a shared buffer well, and the dropping fluid surface disconnects each leg at in a programmable sequence. This approach could enable multi-step laboratory assays to be converted into simple point-of-care devices that have high performance yet remain easy to use.

1 January 2013 in Surgical Neurology International
Verified
Journal Article
Open access
BLBarry Lutz
Barry Lutz
PVPranav Venkataraman
Pranav Venkataraman
SBSamuelR Browd
SamuelR Browd
The most common treatment for hydrocephalus is placement of a cerebrospinal fluid shunt to supplement or replace lost drainage capacity. Shunts are life-saving devices but are notorious for high failure rates, difficulty of diagnosing failure, and limited control options. Shunt designs have changed little since their introduction in 1950s, and the few changes introduced have had little to no impact on these long-standing problems. For decades, the community has envisioned a "smart shunt" that could provide advanced control, diagnostics, and communication based on implanted sensors, feedback control, and telemetry. The most emphasized contribution of smart shunts is the potential for advanced control algorithms, such as weaning from shunt dependency and personalized control. With sensor-based control comes the opportunity to provide data to the physician on patient condition and shunt function, perhaps even by a smart phone. An often ignored but highly valuable contribution would be designs that correct the high failure rates of existing shunts. Despite the long history and increasing development activity in the past decade, patients are yet to see a commercialized smart shunt. Most smart shunt development focuses on concepts or on isolated technical features, but successful smart shunt designs will be a balance between technical feasibility, economic viability, and acceptable regulatory risk. Here, we present the status of this effort and a framework for understanding the challenges and opportunities that will guide introduction of smart shunts into patient care.

26 May 2021 in Science Translational Medicine
Verified
Journal Article
Open access
PDF file
NMNicola F. Müller
Nicola F. Müller
CWCassia Wagner
Cassia Wagner
CFChris D. Frazar
Chris D. Frazar
PRPavitra Roychoudhury
Pavitra Roychoudhury
JLJover Lee
Jover Lee
TBTrevor Bedford
Trevor Bedford
Initial SARS-CoV-2 dynamics in Washington State were driven by regional interventions and introductions of variants differing in viral loads.

1 November 2019 in The Journal of Molecular Diagnostics
Verified
Journal Article
Closed access
AOAmy Oreskovic
Amy Oreskovic
NBNorman D. Brault
Norman D. Brault
NPNuttada Panpradist
Nuttada Panpradist
JLJames J. Lai
James J. Lai
BLBarry Lutz
Barry Lutz

17 December 2021 in Science Advances
Verified
Journal Article
Open access
NPNuttada Panpradist
Nuttada Panpradist
EKEnos C. Kline
Enos C. Kline
RARobert G. Atkinson
Robert G. Atkinson
MRMichael Roller
Michael Roller
QWQin Wang
Qin Wang
BLBarry Lutz
Barry Lutz
A unique four-plexed RT-LAMP test kit operated by health workers can provide faster, more sensitive results than laboratory tests.